Colchicine After Electrocardioversion for Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 416 participants.
Also called NCT05890664
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 416 participants
- Registry
-
NCT05890664
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT05890664. Randomized; triple masking; primary purpose treatment. Start 2024-04-14 (actual); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine After Electrocardioversion for Atrial Fibrillation
- Acronym
- COLECTRO-AF
- Condition
- Atrial Fibrillation
- Condition
- Cardiac Arrhythmia
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital, Basel, Switzerland
- Collaborator
- Swiss Heart Foundation
- Collaborator
- Fondation Machaon, Switzerland, Genf
- Collaborator
- Foundation for Cardiovascular Research Basel
Record details
- Record id
cardio:ct-nct05890664- Content hash
537c02d7c4a69dbf20e3b5e4649238786cc05b5d4078acd53bab7120b0482743